Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLiabilities from Discontinued OperationsMinority InterestNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

P3 Health Partners (PIII) Short-term Investments (2019 - 2025)

Historic Short-term Investments for P3 Health Partners (PIII) over the last 7 years, with Q3 2025 value amounting to $748000.0.

  • P3 Health Partners' Short-term Investments fell 8543.61% to $748000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $748000.0, marking a year-over-year decrease of 8543.61%. This contributed to the annual value of $5.3 million for FY2024, which is 1456.44% up from last year.
  • As of Q3 2025, P3 Health Partners' Short-term Investments stood at $748000.0, which was down 8543.61% from $746000.0 recorded in Q2 2025.
  • In the past 5 years, P3 Health Partners' Short-term Investments registered a high of $5.6 million during Q2 2023, and its lowest value of $54000.0 during Q4 2021.
  • Its 5-year average for Short-term Investments is $2.5 million, with a median of $1.2 million in 2023.
  • As far as peak fluctuations go, P3 Health Partners' Short-term Investments crashed by 9034.03% in 2022, and later skyrocketed by 63946.84% in 2023.
  • Quarter analysis of 5 years shows P3 Health Partners' Short-term Investments stood at $54000.0 in 2021, then soared by 1603.7% to $920000.0 in 2022, then soared by 401.52% to $4.6 million in 2023, then increased by 14.56% to $5.3 million in 2024, then crashed by 85.85% to $748000.0 in 2025.
  • Its Short-term Investments was $748000.0 in Q3 2025, compared to $746000.0 in Q2 2025 and $1.2 million in Q1 2025.